Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 30 01 2021
revised: 25 03 2021
accepted: 30 03 2021
pubmed: 13 4 2021
medline: 12 1 2022
entrez: 12 4 2021
Statut: ppublish

Résumé

Childhood Absence Epilepsy (CAE) accounts for approximately 10% of all pediatric epilepsies. Current treatments for CAE are ineffective in approximately 1/3 of patients and can be associated with severe side effects such as hepatotoxicity. Certain cannabinoids, such as cannabidiol (CBD), have shown promise in the treatment of pediatric epilepsies. However, CBD remains limited or prohibited in many jurisdictions, and has not been shown to have efficacy in CAE. Modulation of the type 1 cannabinoid receptor (CB1R) may provide more desirable pharmacological treatments. Genetic Absence Epilepsy Rats from Strasbourg (GAERS) model many aspects of CAE, including cortical spike and wave discharges (SWDs). We have recently demonstrated that Δ

Identifiants

pubmed: 33845076
pii: S0028-3908(21)00107-6
doi: 10.1016/j.neuropharm.2021.108553
pii:
doi:

Substances chimiques

3-(2-nitro-1-phenylethyl)-2-phenyl-1H-indole 0
Arachidonic Acids 0
Cannabinoid Receptor Agonists 0
Endocannabinoids 0
Glycerides 0
Indoles 0
Receptor, Cannabinoid, CB1 0
glyceryl 2-arachidonate 8D239QDW64

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108553

Subventions

Organisme : CIHR
ID : 10677
Pays : Canada

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Andrew J Roebuck (AJ)

Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK, S7N 5E5, Canada; School of Liberal Arts, Yukon University, Whitehorse, YT, Y1A 5K4, Canada.

Quentin Greba (Q)

Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK, S7N 5E5, Canada.

Anna-Maria Smolyakova (AM)

College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, S7N 2Z4, Canada.

Mariam Alaverdashvili (M)

College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, S7N 2Z4, Canada.

Wendie N Marks (WN)

Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK, S7N 5E5, Canada.

Sumanta Garai (S)

Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, United States.

Samantha L Baglot (SL)

Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 4N1, Canada.

Gavin Petrie (G)

Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 4N1, Canada.

Stuart M Cain (SM)

Michael Smith Laboratories and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.

Terrance P Snutch (TP)

Michael Smith Laboratories and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.

Ganesh A Thakur (GA)

Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, United States.

Matthew N Hill (MN)

Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 4N1, Canada.

John G Howland (JG)

Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK, S7N 5E5, Canada. Electronic address: john.howland@usask.ca.

Robert B Laprairie (RB)

College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, S7N 2Z4, Canada; Department of Pharmacology, College of Medicine, Dalhousie University, Halifax, NS, Canada, B3H 4R2. Electronic address: robert.laprairie@usask.ca.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH